Óscar Santos
University of Antioquia
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Óscar Santos.
Journal of Gastroenterology and Hepatology | 2018
Omar Yesid Martínez-Casas; Gabriel Sebastián Díaz-Ramírez; Juan Ignacio Marín-Zuluaga; Octavio Muñoz-Maya; Óscar Santos; Jorge Hernando Donado-Gómez; Juan Carlos Restrepo-Gutiérrez
Drug‐induced autoimmune hepatitis (DIAIH) is an adverse effect associated with several drugs that usually occurs acutely, with variable latency, and it may potentially be mortal. There are a few reports and studies about DIAIH.
Revista Colombiana de Gastroenterología | 2017
Diana Carolina Moncada; Octavio Germán Muñoz Maya; Daguer Salomón; Óscar Santos; Juan Ignacio Marín Zuluaga; Sergio Iván Hoyos Duque; Carlos Ernesto Guzmán Luna; Álvaro Mena Hurtado; Juan Carlos Restrepo Gutiérrez
Introduccion: la hepatitis B es una causa importante de trasplante hepatico; produce 1 millon de muertesxa0anuales. El uso de inmunoglobulina antihepatitis B en dosis altas y analogos de nucleosidos redujeron en unxa090% la reinfeccion del injerto.Objetivo: evaluar la eficacia de dosis bajas de inmunoglobulina postrasplantexa0para prevenir la reinfeccion del injerto.Metodologia: serie de casos retrospectiva de pacientes trasplantadosen el Hospital “Pablo Tobon Uribe”, entre enero de 2004 y septiembre de 2014, que recibieron inmunoglobulinaxa0despues del trasplante. Se evaluaron la carga viral de hepatitis B, las transaminasas y los marcadoresxa0serologicos para documentar recaida, ademas de variables como mortalidad, complicaciones, disfuncion delxa0injerto, reacciones adversas y costos.Resultados: fueron 18 pacientes trasplantados con hepatitis B; 50%tenia hepatocarcinoma; 22%, cirrosis; y 22%, insuficiencia hepatica aguda. La mediana de seguimiento fuexa0de 43,27 meses (14,7-65,2). De los pacientes, 2 tuvieron antigeno de superficie positivo en el postrasplantexa0y en 1 hubo recaida con carga viral positiva a los 41 meses. La tasa de reinfeccion del injerto fue del 5,5%.xa0No hubo muertes. Se estimo que el costo de usar dosis bajas de inmunoglobulina fue menor comparado conxa0las dosis altas a 6 meses de terapia; sin embargo, no se hizo estudio de costo-efectividad. La disfuncion delxa0injerto fue del 10% a 33 meses.Conclusion: con dosis bajas de inmunoglobulina se previno la reinfeccionxa0del injerto, similar a lo reportado en otras series. Mientras los esquemas libres de inmunoglobulina logranxa0demostrar su utilidad a largo plazo, usar dosis bajas de inmunoglobulina sigue siendo util.
Revista Colombiana de Gastroenterología | 2015
Octavio Muñoz; Laura Ovadía; Yesid Saavedra; Juan Carlos Restrepo; Carlos Yepes; Óscar Santos; Juan Ignacio Marín; Sergio Hoyos; Carlos Guzmán; Álvaro Mena; Gonzalo Correa
Liver transplantation protocols have been extended to people over 65 years of age who had previously beenxa0excluded from protocols due to the increased morbidity and mortality rates associated with age. This studyaims to identify survival rates and complications in patients over 65 years who have undergone liver transplantation.xa0Medical records of patients older than 65 who underwent liver transplantation in the period betweenSeptember 2004 and November 2010 at the Hospital Pablo Tobon Uribe in Medellin, Colombia were analyzed.xa0We studied 27 patients with an average age of 67 years. The 30 day post-transplant survival rate was 85.2%,xa0at one year the survival rate was 70.4%, and at five years it was 63%. An evaluation of post-transplant complicationsxa0found that the most frequent complications were massive bleeding and nosocomial infections. Thexa0main causes of death were cardiovascular events. Conclusion: Proper patient selection allows those overxa065 years of age to become candidates for liver transplantation with a good actuarial 5-year survival rate andxa0better quality of life.
Jcr-journal of Clinical Rheumatology | 2009
Luis A. González; Óscar Santos; Julián Montoya; Gloria Vásquez; Juan P. Restrepo; Clara I. Hurtado; Luis Alfonso Correa; Luis Alberto Ramírez
Giant cell arteritis (GCA), the most common vasculitis in elderly individuals in Western countries, is a largeand medium-sized blood vessel systemic vasculitis characterized by the granulomatous involvement of the aorta with a predilection for the extracraneal branches of the carotid artery. GCA is usually seen in patients over 50 years of age primarily of white ethnicity and less frequently among African Americans, particularly men. Characteristic manifestations include headache, scalp tenderness, jaw claudication, ocular symptoms, polymyalgia rheumatica, and an elevated erythrocyte sedimentation rate (ESR). Scalp necrosis is an extremely rare manifestation which has been associated with severity and a bad prognosis. Herein, we present an unusual case of GCA in an African-Colombian who developed an extensive scalp necrosis.
Revista Colombiana de Gastroenterologia | 2012
Óscar Santos; Juan Marín; Octavio Muñoz; Álvaro Mena; Carlos Guzmán; Sergio Hoyos; Juan Carlos Restrepo; Gonzalo Correa
Gastroenterología y Hepatología | 2012
Óscar Santos; Edison Muñoz Ortiz; Camilo Pérez; Juan Carlos Restrepo
Gastroenterología y Hepatología | 2013
Octavio Muñoz; Pablo Villa; Carolina Echeverri; Óscar Santos; Juan-Carlos Restrepo; Juan-Ignacio Marín; Sergio Hoyos; Carlos Guzmán; Álvaro Mena; Gonzalo Correa
Gastroenterología y Hepatología | 2018
Omar Yesid Martínez Casas; Gabriel Sebastián Díaz Ramírez; Juan Ignacio Marín Zuluaga; Óscar Santos; Octavio Germán Muñoz Maya; Jorge Hernando Donado Gómez; Juan Carlos Restrepo Gutiérrez
Revista Colombiana de Gastroenterologia | 2015
Octavio Muñoz; Laura Ovadía; Yesid Saavedra; Juan Carlos Restrepo; Carlos Yepes; Óscar Santos; Juan Ignacio Marín; Sergio Hoyos; Carlos Guzmán; Álvaro Mena; Gonzalo Correa
Colombia Medica | 2015
Óscar Santos; Mauricio Londoño; Juan Marín; Octavio Muñoz; Álvaro Mena; Carlos Guzmán; Sergio Hoyos; Juan Carlos Restrepo; María Patricia Arbeláez; Gonzalo Correa